Lin Bao

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Renal Cell Carcinoma

Energy Transfer

Radical Prostatectomy

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Hailong Ruan, Sen Li, Lin Bao, Xiaoping Zhang
Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma. Oncogene (2022)
Hailong Ruan, Lin Bao, Zhen Tao, Ke Chen
Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer. Cancer immunology research 9 (7) (2021)
Hailong Ruan, Sen Li, Lin Bao, Xiaoping Zhang
Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma. Oncogene 39 (38) (2020)